Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin B direct hemoperfusion: a retrospective cohort study

Direct hemoperfusion with polymyxin B-immobilized fiber column (PMX-DHP) could improve the hemodynamic status of septic shock patients. As PMX-DHP is an invasive and costly procedure, it is desirable to estimate the therapeutic effect before performing the therapy. However, it is still unclear when...

Full description

Saved in:
Bibliographic Details
Published in:Journal of intensive care 2016-10, Vol.4 (1), p.64-64, Article 64
Main Authors: Yamada, Hiroyuki, Tsukamoto, Tatsuo, Narumiya, Hiromichi, Oda, Kazumasa, Higaki, Satoshi, Iizuka, Ryoji, Yanagita, Motoko, Deguchi, Masako
Format: Article
Language:English
Subjects:
Care and treatment
Health aspects
Polymyxin
Septic shock
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Direct hemoperfusion with polymyxin B-immobilized fiber column (PMX-DHP) could improve the hemodynamic status of septic shock patients. As PMX-DHP is an invasive and costly procedure, it is desirable to estimate the therapeutic effect before performing the therapy. However, it is still unclear when this therapy should be started and what type of sepsis it should be employed for. In this study, we retrospectively examined the clinical effect of patients treated with PMX-DHP by using central venous pressure (CVP). Seventy patients who received PMX-DHP for septic shock during the study period were recruited and divided into a low CVP group (  = 33, CVP 
ISSN:2052-0492
2052-0492
DOI:10.1186/s40560-016-0186-8